Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease. Ann Rheum Dis 2016;75:1268-71.Smolen J S, Collaud B S, Boers M, et al. Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease[J]. Ann Rheum Dis, ...
Diseases & Conditions Rheumatoid Arthritis (RA) Diseases & Conditions Rheumatoid Arthritis of the Cervical Spine news What’s Next for Rheumatoid Arthritis Prevention Trials? news Rheumatoid Arthritis: Whole-Food Diet May Be Protective news Changes in Gut Microbiome Signal Rheumatoid Arthritis Onset ...
significance of our meta-analysis and the results of our calculations of publication bias support the conclusion that treatment with an anti-TNF drug plus methotrexate is more effective than methotrexate alone and might therefore be considered as standard therapy for patients with rheumatoid arthritis. ...
Rheumatoid arthritis is a painful inflammatory condition affecting the joints and tendons, which is typically characterized by periods of increased disease activity. Prof. Dr. Gerd-Rüdiger Burmester, head of Charité's Medical Department, Division of Rheumatology and Clinical Immunology, conducted a stud...
Methotrexate and sulfasalazine represent examples of chemotherapies in which the short-term efficacy and toxicities, at least in rheumatoid arthritis, have been carefully documented by controlled trials. The limited information available on cyclosporin A, combination chemotherapy, and radiotherapy is ...
Biotherapies and other new treatments introduced over the last few years have considerably enriched the therapeutic armamentarium for rheumatoid arthritis. Nevertheless, primary refractoriness or secondary escape phenomenon may occur, indicating a need for identifying new treatment targets. Promising candidates ...
Adalimumab is currently in clinical trials for additional therapeutic uses, namely Crohn's disease and coronary artery disease.doi:10.1331/108658003321480812PeggyPiascikJournal of the American Pharmaceutical Association (Washington,D.C. : 1996)Piascik P. New antibody approved for the treatment of rheuma-...
Kinase inhibitors: A new tool for the treatment of rheumatoid arthritisdoi:10.1016/j.clim.2013.04.007KinaseinhibitorsRheumatoidarthritisDespite aggressive immunosuppression with biologics and traditional DMARDs, achieving disease remission remains an unmet goal for most rheumatoid arthritis (RA) patients. In...
Critical Review of Clinical Assessment Techniques for Rheumatoid Arthritis Trials: New Developments 来自 Taylor & Francis 喜欢 0 阅读量: 29 作者: Bellamy,N.摘要: Since the early work of Taylor (1937) and Steinbrocker (1949), clinical methods of assessing the response of patients to anti-...
Celecoxib is an effective anti-inflammatory, analgesic and antipyretic agent therapeutically utilised in the management of osteoarthritis and rheumatoid arthritis. In addition, celecoxib has some novel therapeutic and pharmacological activities. Celecoxib inhibits anti-apoptotic kinase activation and is the ...